Skip to content
This repository has been archived by the owner on Dec 4, 2024. It is now read-only.

Commit

Permalink
Update index.qmd
Browse files Browse the repository at this point in the history
Updated some of the text and the layout of the brief WP descriptions.
  • Loading branch information
danielwitte authored Jun 21, 2024
1 parent 226527a commit 8754864
Showing 1 changed file with 22 additions and 73 deletions.
95 changes: 22 additions & 73 deletions index.qmd
Original file line number Diff line number Diff line change
Expand Up @@ -4,24 +4,15 @@ title: "Overview"

## What is DP-Next?

DP-Next is a project in development aimed at developing a sustainably
effective strategy for prevention of Type 2 Diabetes in Denmark,
Greenland and the Faroe Islands. The project is currently in development
and seeking funding. The full name of the project is: Sustainable Type 2
Diabetes Prevention for the 21st Century. We call it DP-Next because we
intend to develop the next generation of Diabetes Prevention strategies.
DP-Next is a project in development aimed at developing a sustainably effective strategy for prevention of Type 2 Diabetes in Denmark, Greenland and the Faroe Islands. The project is currently in development and seeking funding. The full name of the project is: Sustainable Type 2 Diabetes Prevention for the 21st Century. We call it DP-Next because we intend to develop the next generation of Diabetes Prevention strategies.

## Why is a new strategy for diabetes prevention necessary?

We have known for over two decades that it is possible *-in principle-*
to prevent Type 2 Diabetes in people at very high risk by encouraging
them to participate in a very intensive lifestyle modification
programme.
We have known for over two decades that it is possible *-in principle-* to prevent Type 2 Diabetes in people at very high risk by encouraging them to participate in a very intensive lifestyle modification programme.

<details>

<summary>The original Diabetes Prevention Studies were conducted around
the turn of the century.</summary>
<summary>The original Diabetes Prevention Studies were conducted around the turn of the century.</summary>

<ul>

Expand All @@ -38,76 +29,34 @@ Study</a> (China)</li>

</details>

Unfortunately, subsequent efforts to translate the benefits from these
efficacy trials into sustainable day to day practice have largely
failed. The first main issue is that the resources and intensity of the
trial interventions are not practically achievable at large scale.
Studies that have applied less intensive lifestyle interventions have
generally shown only temporary impacts on weight, but no long-term
impact on diabetes incidence. The second main issue is that the
particular subgroup of pre-diabetes recruited into the trials (IGT) is
the group at highest diabetes risk, but is rarely identified in daily
practice especially since HbA1c has replaced the oral glucose tolerance
test (OGTT) as the main diagnostic tool in Europe and the US since 2014.
Unfortunately, subsequent efforts to translate the benefits from these efficacy trials into sustainable day to day practice have largely failed. The first main issue is that the resources and intensity of the trial interventions are not practically achievable at large scale. Studies that have applied less intensive lifestyle interventions have generally shown only temporary impacts on weight, but no long-term impact on diabetes incidence. The second main issue is that the particular subgroup of pre-diabetes recruited into the trials (IGT) is the group at highest diabetes risk, but is rarely identified in daily practice especially since HbA1c has replaced the oral glucose tolerance test (OGTT) as the main diagnostic tool in Europe and the US since 2014.

In other words:

- The population with high diabetes risk today is much more
heterogeneous compared to the participants in the original
prevention trials
- The intensity of intervention applied in the efficacy trials is not
pragmatically or sustainably achievable.
- The population with high diabetes risk today is much more heterogeneous compared to the participants in the original prevention trials
- The intensity of intervention applied in the efficacy trials is not pragmatically or sustainably achievable.

### What has changed since?

The past decades have brought a lot of new opportunities for diabetes
prevention, which are currently often underutilised:
The past decades have brought a lot of new opportunities for diabetes prevention, which are currently often underutilised:

- Extensive, linkable health registers with population-wide coverage
- Extensive, linkable health registers with population-wide coverage
- Advanced statistical and machine learning methods
- Deeper insight into psychosocial barriers for sustainable health
behaviour change
- Stronger experience with methods for development of complex
interventions
- Expanding evidence for substantial heterogeneity in (pre)diabetes
and diabetes risk
- Advanced technology for real time measurements (CGM, sleep, physical
activity)
- Deeper insight into psychosocial barriers for sustainable health behaviour change
- Stronger experience with methods for development of complex interventions
- Expanding evidence for substantial heterogeneity in (pre)diabetes and diabetes risk
- Advanced technology for real time measurements (CGM, sleep, physical activity)
- Widespread adoption of communication via smartphones and use of apps

## What will DP-Next do?

We aim to use these developments to design and deliver a sustainably
effective strategy for prevention of T2D in Denmark, Greenland and the
Faroe Islands.

We will work towards this aim in four Work Packages (WP) across all
seven Steno Diabetes Centres:

![There are 5 Steno Diabetes Centers in Denmark, one in Greenland and
one on the Faroe
Islands.](images/map-steno-centers.jpg){#fig-map-steno-centers}

WP1 (Management and Collaboration) will manage the project and foster
deep collaboration between all partners. WP2 (Risk Prediction) will
develop an exclusively register-based diabetes risk prediction model for
the entire Danish, Greenlandic and Faroese populations, applying
advanced statistical and machine learning approaches on a wide set of
risk indicators. It will map out meaningful subgroups and validate
internally and in external populations. WP3 (Heterogeneity) will map out
heterogeneity in T2D risk in a subgroup of \~1000 participants with
HbA1c-based pre-diabetes with a special focus on regional fat
distribution, hepatic steatosis and insulin resistance. WP4
(Intervention Development) will develop an intervention for sustainable
primary diabetes prevention based on co-creation, a systems approach and
the “Complex Interventions” framework and evaluate the pragmatic
feasibility of intervention components in two risk subgroups in real
life practical settings.

See the WP tabs for more details about each Work Packages

## Who are we?

DP-Next will be carried out by a cross disciplinary team of
epidemiologists, clinicians, health scientists and data scientists
across all seven Steno Diabetes Centres.
We aim to use these developments to design and deliver a sustainably effective strategy for prevention of T2D in Denmark, Greenland and the Faroe Islands.

We will work towards this aim in four Work Packages (WP) across all seven Steno Diabetes Centres:

![There are 5 Steno Diabetes Centers in Denmark, one in Greenland and one on the Faroe Islands.](images/map-steno-centers.jpg){#fig-map-steno-centers}

- WP1 (Management and Collaboration) will manage the project and foster deep collaboration between all partners.
- WP2 (Risk Prediction) will develop an exclusively register-based diabetes risk prediction model for the entire Danish, Greenlandic and Faroese populations, applying advanced statistical and machine learning approaches on a wide set of risk indicators. It will map out meaningful subgroups and validate internally and in external populations.
- WP3 (Heterogeneity) will map out heterogeneity in T2D risk in a new deeply phenotyped cohort of 1000 participants with HbA1c-based pre-diabetes with a core protocol focused on regional fat distribution, hepatic steatosis, beta cell function and insulin resistance plus the creation of an extensive biobank and the ambition for an extended protocol.
- WP4 (Intervention Development) will develop an intervention for sustainable primary diabetes prevention based on co-creation, a "Participatory System Dynamics Approach" and the "Complex Interventions" framework and evaluate the pragmatic feasibility of intervention components in specific risk subgroups in real life practical settings.

0 comments on commit 8754864

Please sign in to comment.